Ergonomie < Ergot dérivé < Ergotamine

Facettes :

List of bibliographic references indexed by Ergot dérivé

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
002B03 (2007)	Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne]	Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader‐blinded monocenter echocardiography study
003125 (2006)	Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Seung Woo Park [Corée du Sud] ; Won Yong Lee [Corée du Sud]	Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
003B32 (2004)	Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada]	Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
003F70 (2003)	Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]	Randomized, double‐blind, 3‐month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor
004114 (2003)	Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]	Double‐blind, single‐dose, cross‐over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease
004165 (2003)	Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne]	Cabergoline versus levodopa monotherapy: A decision analysis
004316 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
004550 (2002)	Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]	Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
004622 (2002)		Drugs to treat autonomic dysfunction in Parkinson's disease
004626 (2002)		DA agonists: ergot derivatives: Bromocriptine
004631 (2002)		DA agonists: Ergot derivatives: Pergolide
004632 (2002)		DA agonists: Ergot derivatives: Lisuride
004633 (2002)		DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC)
004634 (2002)		DA agonists: Ergot derivatives: Cabergoline
004707 (2001)	William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie]	Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations
004719 (2001)	Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]	Poetic talent unmasked by treatment of Parkinson's disease
004759 (2001)	Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]	Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
004933 (2000)	Robert A. Hauser [États-Unis] ; William C. Koller [États-Unis] ; Jean P. Hubble [États-Unis] ; Teresita Malapira [États-Unis] ; Karen Busenbark [États-Unis] ; C. Warren Olanow [États-Unis]	Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease
004945 (2000)	Claudia Ramaker [Pays-Bas] ; Willem Johan T. Van De Beek [Pays-Bas] ; Martijn J. J. Finken [Pays-Bas] ; Bob J. J. Van Hilten [Pays-Bas]	The efficacy and safety of adjunct bromocriptine therapy for levodopa‐induced motor complications: A systematic review
004B08 (2000)	Jaime Kulisevsky [Espagne] ; Carmen García-Sánchez [Espagne] ; Marcelo L. Berthier [Espagne] ; Manel Barbanoj [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Armando Estévez-González [Espagne]	Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients
004C27 (1999)	J. Eric Ahlskog [États-Unis] ; Ryan J. Uitti [États-Unis] ; Michael K. O'Connor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Joseph Y. Matsumoto [États-Unis] ; Kathy F. Stark [États-Unis] ; Margaret F. Turk [États-Unis] ; Omer L. Burnett [États-Unis]	The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Ergot dérivé" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Ergot dérivé" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Ergot dérivé
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024